Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

Start Learning

Touch Loading image
JOURNALS
Start Learning
New hepatitis B guidelines released by WHO
3d illustration of HIV virus. Medical concept
JOURNALS
Start Learning
World AIDS Day 2024
CONFERENCE HUB
Start Learning
Evolving HIV diagnostic technologies: A new era of precision
touchEXPERT OPINIONS
Start Learning
Demystifying virology: The link between the HIV life cycle and ART
Coronavirus outbreak. Pathogen affecting the respiratory tract. COVID-19 infection. Concept of a pandemic, viral infection. Coronavirus inside a human. Viral infection. 3D illustration
JOURNALS
Start Learning
The start-to-finish of vaccines: Innovation and challenges at the World Vaccine Congress Europe 2024
CONFERENCE HUB
Start Learning
Antiretroviral management of HIV in clinical practice: integration of the latest data
JOURNALS
Start Learning
Greatest Hits of 2024
touchMEETING HIGHLIGHTS
Start Learning
FMX 2023 – Boosting adult immunizations: Practical solutions for optimization
Sponsored content
CONFERENCE HUB
Start Learning
Pioneering HIV vaccine research through regional advances and vaccine equity
CONFERENCE HUB
Start Learning
Antiretroviral therapy updates at CROI 2024: emerging treatment strategies in HIV

to view Favourites, Keep Notes and Track CME Credits

Favourites
Driving Forward After COVID-19: A Call for Continued Investment in Research on Differentiated Models of HIV Service Delivery for Vulnerable Populations Globally
View
Greatest Hits of 2024
View
Vaccinating children in endemic regions could be the most efficient strategy for tackling mpox in the Democratic Republic of the Congo
View
Antiretroviral management of HIV in clinical practice: integration of the latest data
View
Real-world study confirms effectiveness of MVA-BN vaccine against mpox
View
Study reveals significant decline in life expectancy in India during COVID-19
View
Highlights from ESCMID Global 2024: Cutting-edge vaccine research and insights
View
New hepatitis B guidelines released by WHO
View
Foreword – touchREVIEWS in Infectious Diseases, Volume 3, Issue 1, 2024
View
Lenacapavir achieves 100% efficacy in landmark HIV prevention trial
View
In Partnership with...
Useful Links:
About us Society Partners Contact Us Permissions Terms & Conditions Privacy Policy Cookie Preferences
Connect With Us:

Other websites from Touch Medical Media:

touchONCOLOGY
touchOPHTHALMOLOGY
touchENDOCRINOLOGY
touchNEUROLOGY
touchCARDIO
touchRESPIRATORY
touchIMMUNOLOGY
touchINFECTIOUS DISEASES
touchHAEMATOLOGY
touchDERMATOLOGY

Copyright® 2024 Touch Medical Media. Touch Medical Media Group Holdings Limited, a private limited company registered in England and Wales at 3 Stockport Exchange | Stockport | Cheshire | SK1 3GG | UK with registered number 08197142.

touchINFECTIOUS DISEASES is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.

Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup